lung cancer screening

Optimizing Smoking Cessation Interventions in Lung Cancer Screening: Insights from the CASTL Trial

By MedXY 07/11/2026

The CASTL trial evaluated efficient combinations of tobacco cessation interventions for smokers undergoing lung cancer screening, identifying loss-framed messaging with nicotine replacement therapy as the most cost-effective strategy.

Clinical Updates news Oncology

Precision in Prevention: The Role of Prediction-Augmented Shared Decision-Making in Enhancing Lung Cancer Screening Uptake

By MedXY 12/28/2025

This review evaluates the impact of integrating risk-prediction models into shared decision-making for lung cancer screening, focusing on clinical implementation strategies that prioritize high-benefit populations.

Clinical Updates news Oncology

Optimizing Patient-Centered Lung Cancer Screening: Insights from the MyLungHealth Randomized Clinical Trial

By MedXY 12/28/2025

This review analyzes the MyLungHealth trial, demonstrating how EHR-integrated, patient-facing tools significantly improve lung cancer screening eligibility identification and CT ordering rates compared to clinician-facing support alone.

news Oncology Respiratory

PLCOm2012 Risk-Based Selection Outperforms NELSON Criteria for Lung Cancer Detection in Germany: Findings from the HANSE Cohort

By MedXY 11/26/2025

In HANSE, PLCOm2012 (6‑year risk ≥1.58%) selected more lung cancers and yielded a lower number needed to screen than NELSON criteria, supporting risk-model selection for CT screening programs, with caveats on generalisability and mortality endpoints.

Clinical Updates news Oncology Specialties

Unraveling the Complexity of Lung Cancer Screening: Comparative Insights from Two Landmark Trials

By MedXY 09/14/2025

Lung cancer screening reduces mortality but varies by risk factors, sex, and cancer histology. Analysis of NELSON and NLST trials highlights histology-driven heterogeneity and suggests broader screening criteria may improve outcomes.